Monday, December 23, 2024
HomeTagsMajesTEC-1 Study

MajesTEC-1 Study

New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the first presentation of Phase 2 data and updated Phase 1 data from the MajesTEC-1...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics